Seleccione otro país
Bienvenido a Lyxor España
Por favor, lea la información importante aquí incluida antes de continuar a nuestra página web

Información relevante 

Los Lyxor ETFs presentados en la página web de lyxoretf.com, pueden ser objeto de restricciones en lo que respecta a la inversión por determinadas personas o en determinados países, en virtud de las distintas regulaciones nacionales aplicables a dichas personas o en dichos países. Cualquier persona que acceda a esta página web desde una jurisdicción en la cual se aplican dichas restricciones tiene que informarse al respecto y observar dichas restricciones. Por consiguiente, le corresponde a usted asegurarse de que, efectivamente está autorizado a invertir en los Lyxor ETFs presentados en esta página web. Invirtiendo en estos productos, usted garantiza a Société Générale que está efectivamente autorizado a invertir. Inversores españoles se deben dirigir a www.lyxoretf.es

La información contenida en esta página web no constituye una oferta o invitación para adquirir o vender los productos aquí descritos a personas sometidas a  jurisdicciones donde:

(a) dicha oferta o invitación no esté autorizada;
(b) Lyxor Asset Management no esté cualificada para hacer dicha oferta o invitación;
(c)  sea ilícito hacer dicha oferta o invitación.

Los ETFs referidos en esta página web no han estado y no estarán registrados conforme al U.S Securities Act de1933, por lo tanto, no pueden ser ofertados ni vendidos en los EE.UU sin registro previo o solo en caso de excepción de registro conforme al  al Securities Act. Por consiguiente, los ETFs listados en esta página web no pueden ser vendidos a “U.S persons”, ni transferidos a los Estados Unidos a menos que dicha transacción esté sujeta a los requisitos de registro conforme a la ley Americana.

Esta página web es de carácter comercial y no de carácter legal. No se garantiza la exactitud, exhaustividad o pertinencia de la información aunque ha sido establecida a partir de fuentes consideradas como fiables.
La información presentada en esta página web se basa en información de mercado constada en un momento dado que puede variar con posterioridad a su publicación. El valor de reembolso de los Lyxor ETFs puede ser inferior al montante de la inversión inicial. En el peor de los casos, los inversores podrían perder hasta la totalidad de su inversión, por lo que se recomienda a los inversores consultar la sección« factores de riesgo » del folleto del producto. El precio de algunos Lyxor ETFs puede ser sensible a riesgos de tipo de cambio entre la cotización del ETF y/o la divisa del índice y/o la divisa del componente del índice.

Todos los LyxorETFs presentados en esta página web han sido aprobados por la “Autorité des Marchés Financiers (AMF)” y son objeto de un folleto aprobado por la AMF y pasaporteado en la CNMV conforme a la Directiva 2003/71/CE. Dichos folletos están disponibles en esta página Web.

La documentación relativa a los Lyxor ETFs preverá métodos de ajuste y de sustitución para tener en cuenta que consecuencias tendría cualquier suceso extraordinario que afecte a uno o varios de los subyacentes de estos productos.

Antes de invertir en un Lyxor ETF, usted debe hacer su propia valoración del riesgo desde un punto de vista legal, fiscal y  contable, sin depender exclusivamente de la información que le proporcionamos y consultando, si lo estima necesario, sus propios asesores en la materia o cualquier otro asesor independiente.

El inversor de ETFs estará expuesto a los siguientes factores de riesgo: Riesgo de pérdida del capital invertido, al no existir ninguna garantía, como consecuencia de un movimiento desfavorable del Índice de Referencia, Riesgo de que el objetivo de gestión solo se cumpla parcialmente, Riesgo de contrapartida como resultado de la utilización de los instrumentos financieros (OTC) formalizados con un establecimiento de crédito. Se recomienda a los inversores que consulten la sección del folleto antes de invertir.

En la medida en que cumpla con la legislación aplicable, ninguna entidad del Grupo Société Générale acepta responsabilidad alguna por las consecuencias financieras o de cualquier otra naturaleza que resulten de la inversión en este producto.

Utilizamos las Cookies para asegurar el correcto funcionamiento de nuestro sitio web, y para recopilar datos estadísticos sobre usuarios de modo que podamos mejorar el sitio web. Si continúa navegando por este sitio web usted aceptará nuestro uso de las Cookies.Para más información o para modificar sus preferencias sobre CookiesHaga click aquí
17 nov 2017

1 down, 3 to go: Trump’s first 365 days 


7 November marked a year to the day that Donald Trump was handed the keys to the kingdom on the US. It’s safe to say it’s been a whirlwind ride since then. The equity markets however have enjoyed some much plainer sailing, but what lies ahead?

Break on through

Not for the first time this year, the S&P 500 has breached its all-time high – a fact that’s easy to overlook given the negative headlines that have plagued the US’s divisive Commander-in-Chief. Yet investors still seem content to price in many of his promises (tax cut, cash repatriation, deregulation, investment plan) and have benefited from a “Goldilocks” scenario: fairly strong growth with low bond yields and a weak dollar.  

Promises vs. prices

Clearly, fundamentals remain impressive and some risks have passed – for now at least it looks less likely the Trump presidency will fail despite all the wailing and gnashing of teeth. The debt ceiling has been raised, at least until 8 December, and tax reform finally appears to be under way. 

Promises vs. prices

Tax cut fight

There will, undoubtedly, be some opposition to overcome – notably from small businesses – so changes are likely, but the GOP should still be able to pass a bill by the end of the year. This will be a huge relief to those investors who’ve been betting on deep tax cuts and driving the S&P 500 ever higher.

It will also be a huge relief to the President, whose policymaking apprenticeship has been troubled to say the least. After the healthcare debacle, he is in desperate need of a major legislative victory to conclude his first year in office. So far, the much-promised fiscal push has, rather ironically, met a bureaucratic brick wall.  

Jerome joins Janet’s dots

We do have the name of the new Fed Chair – the centrist, down-to-earth Jerome Powell will take office in February, once Janet Yellen’s term comes to an end. Whilst not the most ardent proponent of de-regulation on the shortlist, Powell has stated his desire to lighten the regulatory load, especially on smaller banks. 

He’s also likely to tread the familiar, gradual path of normalisation laid down by his predecessor. At least, that’s what the market – which received his nomination warmly - is hoping for. Continuity is king on Wall Street. Any deviation from that path could expose the true scale of the equity market’s vulnerability to Fed balance sheet reduction.

Still, decent growth and little in the way of wage pressure is translating into solid margins, which in turn fuels firmer earnings per share growth as has been amply demonstrated by the results of the current earnings season to date. Positive surprises have been plentiful. In truth then, it‘s all suggestive of a very conducive environment for equities. And many investors do seem to believe the run will continue, at least for another 12-18 months until the economy starts slowing, because they can’t see any more catalysts for change. 

No more than neutral

Yet the S&P 500 is up by 20%+ over the last 12 months (at time of writing), which looks stretched to us.  We’re neutral overall on US equities and feel the need to be more selective than the headline figures suggest. Details on tax reform are sketchy, but the odds of an accord seem to have increased. Looming mid-terms add to the pressure for the Republicans. Sector calls are difficult at this stage, but we do expect domestic-focused areas to benefit most. We still favour large-caps over their smaller peers as well. We’re bullish on banks over the long term, given the prospects for de-regulation, but low inflation could prove a headwind for a while yet.

Risk Warning 

For professional clients and qualified investors only.  All data; Lyxor Cross Asset Research Team, 9 November 2017.Past performance is of course no guide to future returns. It is important for potential investors to evaluate the risks described below and in the fund prospectus which can be found on www.lyxoretf.com 

CAPITAL AT RISK: ETFs are tracking instruments: Their risk profile is similar to a direct investment in the Underlying Index. Investors’ capital is fully at risk and investors may not get back the amount originally invested.

REPLICATION RISK: The fund objectives might not be reached due to unexpected events on the underlying markets which will impact the index calculation and the efficient fund replication.

COUNTERPARTY RISK: Investors are exposed to risks resulting from the use of an OTC Swap with Societe Generale. In-line with UCITS guidelines, the exposure to Societe Generale cannot exceed 10% of the total fund assets. Physically replicated ETFs may have counterparty risk resulting from the use of a Securities Lending Programme.                                                                                                                                   

UNDERLYING RISK: The Underlying Index of a Lyxor ETF may be complex and volatile. When investing in commodities, the Underlying Index is calculated with reference to commodity futures contracts exposing the investor to a liquidity risk linked to costs such as cost of carry and transportation. ETFs exposed to Emerging Markets carry a greater risk of potential loss than investment in Developed Markets as they are exposed to a wide range of unpredictable Emerging Market risks.

CURRENCY RISK: ETFs may be exposed to currency risk if the ETF is denominated in a currency different to that of the Underlying Index they are tracking. This means that exchange rate fluctuations could have a negative or positive effect on returns.                                                         

LIQUIDITY RISK: Liquidity is provided by registered market-makers on the respective stock exchange where the ETF is listed, including Societe Generale. On exchange liquidity may be limited as a result of a suspension in the underlying market represented by the Underlying Index tracked by the ETF; a failure in the systems of one of the relevant stock exchanges, Societe Generale or other market-maker systems; or an abnormal trading situation or event.This document is for the exclusive use of investors acting on their own account and categorized either as “eligible counterparties” or “professional clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. It is not directed at retail clients. In Switzerland, it is directed exclusively at qualified investors.

Research Disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.

Connect with us on linkedin